Amgen discounts cholesterol drug, but payers want more
March 17, 2017 at 16:49 PM EDT
March 17 (Reuters) - Amgen Inc sells its cholesterol-lowering drug Repatha at a discount of about 30 percent to its U.S. list price of $14,000 a year, but the largest pharmacy benefit managers say they want lower prices after new data suggested more patients should be treated with the drug.